141 related articles for article (PubMed ID: 28043105)
1. Association Study of Polymorphisms of Epidermal Growth Factor and Epidermal Growth Factor Receptor With Benign Prostatic Hyperplasia in a Korean Population.
Kim SK; Park HK; Choi HS; Yoo KH; Chung JH
Int Neurourol J; 2016 Dec; 20(4):363-370. PubMed ID: 28043105
[TBL] [Abstract][Full Text] [Related]
2. Association between epidermal growth factor (EGF) and EGF receptor gene polymorphisms and end-stage renal disease and acute renal allograft rejection in a Korean population.
Kim BW; Kim SK; Heo KW; Bae KB; Jeong KH; Lee SH; Kim TH; Kim YH; Kang SW
Ren Fail; 2020 Nov; 42(1):98-106. PubMed ID: 31906817
[No Abstract] [Full Text] [Related]
3. Promoter Polymorphism (rs12770170, -184C/T) of Microseminoprotein, Beta as a Risk Factor for Benign Prostatic Hyperplasia in Korean Population.
Ban JY; Yoo KH
Int Neurourol J; 2014 Jun; 18(2):63-7. PubMed ID: 24987558
[TBL] [Abstract][Full Text] [Related]
4. Association between polymorphisms of estrogen receptor 2 and benign prostatic hyperplasia.
Kim SK; Chung JH; Park HC; Kim JH; Ann JH; Park HK; Lee SH; Yoo KH; Lee BC; Kim YO
Exp Ther Med; 2015 Nov; 10(5):1990-1994. PubMed ID: 26640585
[TBL] [Abstract][Full Text] [Related]
5. Can the intraprostatic concentration of epidermal growth factor influence the variance of serum prostate specific antigen levels in patients with benign prostatic hyperplasia?
Di Silverio F; Sciarra A; Monti S; Casale P; Seccareccia F
J Urol; 1999 Jan; 161(1):128-32. PubMed ID: 10037384
[TBL] [Abstract][Full Text] [Related]
6. Involvement of fibroblast growth factor receptor genes in benign prostate hyperplasia in a Korean population.
Park HJ; Kim SK; Kim JW; Lee SH; Yoo KH; Chung JH
Dis Markers; 2013; 35(6):869-75. PubMed ID: 24385678
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide synthase 2 gene polymorphisms are associated with prostatic volume in Korean men with benign prostatic hyperplasia.
Yoo KH; Kim SK; Chung JH; Chang SG
Asian J Androl; 2010 Sep; 12(5):690-6. PubMed ID: 20562898
[TBL] [Abstract][Full Text] [Related]
8. SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic receptor antagonists.
Gu X; Na R; Huang T; Wang L; Tao S; Tian L; Chen Z; Jiao Y; Kang J; Zheng S; Xu J; Sun J; Qi J
J Urol; 2013 Aug; 190(2):615-9. PubMed ID: 23499746
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the α-adrenergic receptor antagonist.
Qian X; Xu D; Liu H; Lin X; Yu Y; Kang J; Sheng X; Xu J; Zheng S; Xu D; Qi J
Aging Male; 2017 Dec; 20(4):250-256. PubMed ID: 28787260
[TBL] [Abstract][Full Text] [Related]
10. Association of BID SNPs (rs8190315 and rs2072392) and clinical features of benign prostate hyperplasia in Korean population.
Seok H; Kim SK; Yoo KH; Lee BC; Kim YO; Chung JH
J Exerc Rehabil; 2014 Dec; 10(6):383-8. PubMed ID: 25610824
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 10-1-6 gene cluster polymorphisms are not associated with benign prostatic hyperplasia in korean population.
Kim SK; Kim YO; Lee BC; Yoo KH; Chung JH
Int Neurourol J; 2014 Mar; 18(1):10-5. PubMed ID: 24729922
[TBL] [Abstract][Full Text] [Related]
12. Association of a Missense ALDH2 Single Nucleotide Polymorphism (Glu504Lys) With Benign Prostate Hyperplasia in a Korean Population.
Seok H; Yoo KH; Kim YO; Chung JH
Int Neurourol J; 2013 Dec; 17(4):168-73. PubMed ID: 24466463
[TBL] [Abstract][Full Text] [Related]
13. Association of IL10, IL10RA, and IL10RB polymorphisms with benign prostate hyperplasia in Korean population.
Yoo KH; Kim SK; Chung JH; Chang SG
J Korean Med Sci; 2011 May; 26(5):659-64. PubMed ID: 21532858
[TBL] [Abstract][Full Text] [Related]
14. Association of LTβR gene polymorphisms with prostate volume in benign prostatic hyperplasia in the Korean population.
Lee SH; Kim SK; Yoo KH; Chung JH; Chang SG
Genet Mol Res; 2015 Dec; 14(4):18607-15. PubMed ID: 26782510
[TBL] [Abstract][Full Text] [Related]
15. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia.
Soulitzis N; Karyotis I; Delakas D; Spandidos DA
Int J Oncol; 2006 Aug; 29(2):305-14. PubMed ID: 16820871
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate.
Sherwood ER; Lee C
World J Urol; 1995; 13(5):290-6. PubMed ID: 8581000
[TBL] [Abstract][Full Text] [Related]
17. Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population.
Oh JJ; Byun SS; Lee SE; Hong SK; Jeong CW; Kim D; Kim HJ; Myung SC
Gene; 2014 Jan; 533(1):86-93. PubMed ID: 24120391
[TBL] [Abstract][Full Text] [Related]
18. Association of Polymorphisms in the Prostate-Specific Antigen (PSA) Gene Promoter with Serum PSA Level and PSA Changes after Dutasteride Treatment in Korean Men with Benign Prostatic Hypertrophy.
Park SW; Kim CS; Lee G
Korean J Urol; 2010 Dec; 51(12):824-30. PubMed ID: 21221201
[TBL] [Abstract][Full Text] [Related]
19. Association of androgen receptor, prostate-specific antigen, and CYP19 gene polymorphisms with prostate carcinoma and benign prostatic hyperplasia in a north Indian population.
Soni A; Bansal A; Mishra AK; Batra J; Singh LC; Chakraborty A; Yadav DS; Mohanty NK; Saxena S
Genet Test Mol Biomarkers; 2012 Aug; 16(8):835-40. PubMed ID: 22731640
[TBL] [Abstract][Full Text] [Related]
20. SPINK1 Promoter Variants Are Associated with Prostate Cancer Predisposing Alterations in Benign Prostatic Hyperplasia Patients.
Winchester D; Ricks-Santi L; Mason T; Abbas M; Copeland RL; Beyene D; Jingwi EY; Dunston GM; Kanaan YM
Anticancer Res; 2015 Jul; 35(7):3811-9. PubMed ID: 26124326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
